Schizophreniform Disorder
📧 Sign up to get email alerts when something new happens for Schizophreniform Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: A Definitive Estrogen Patch Study (ADEPT) [Phase 2]
A phase 2 clinical trial (ADEPT) evaluating an estrogen patch for schizophrenia and related disorders has completed. Results were posted in …
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Clinical Estradiol Trial in Women With Schizophrenia [Phase 2]
A Phase 2 clinical trial of estradiol in women with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia [Phase 4]
Phase 4 clinical trial exploring selective estrogen receptor modulators as a potential treatment for psychotic symptoms in schizophrenia; th…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia [Phase 4]
A Phase 4 trial evaluated the efficacy and safety of A-prexa compared with Zyprexa (olanzapine) in patients with schizophrenia-spectrum diso…
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia [Phase 4]
Phase 4 clinical trial explored the effects of pravastatin on cholesterol, inflammation, and cognition in individuals with schizophrenia and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Association of Amisulpride Response in Schizophrenia With Brain Image [Phase 4]
A Phase 4 clinical trial update examining the association between brain imaging findings and response to amisulpride in schizophrenia and sc…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine
This completed clinical trial evaluated body mass index and metabolic changes after switching from olanzapine, risperidone, or quetiapine to…
-
CLINICAL_TRIALS trial_result · 2013-11-12Clinical Trial Update: A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis [Phase 4]
A Phase 4 trial compared risperidone long-acting injection with an oral antipsychotic in early psychosis; results were posted in 2013 and in…
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders [Phase 4]
Phase 4 clinical trial update reporting efficacy and safety of Risperidone long-acting injectable in schizophrenia-spectrum disorders.
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
This update reports results from a youth-focused trial evaluating the effectiveness and tolerability of a second-generation antipsychotic ac…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy [NA]
This entry reports the completion of a clinical trial evaluating the impact of cognitive-behavioral therapy on recovery from psychosis in in…
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects [Phase 2]
Phase 2 clinical trial evaluating olanzapine in combination with zonisamide sustained-release to prevent weight gain in patients with schizo…
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia [Phase 4]
Phase 4 trial evaluating ramelteon as an adjunct therapy in non-diabetic patients with schizophrenia and related disorders; results have bee…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Schizophrenic Patients in Integrated Care [Phase 4]
Phase 4 clinical trial sponsored by AstraZeneca evaluating schizophrenia-related conditions was terminated, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl [Phase 1]
This completed Phase 1 pharmacokinetic study investigates how calorie intake and fat content influence the absorption and exposure of lurasi…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder [Phase 1]
This Phase 1 safety and pharmacokinetic study evaluated the extended-release osmotic-release (ER OROS) formulation of paliperidone in pediat…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients
The trial evaluated the safety and effectiveness of risperidone for acute psychosis in patients with schizophrenia or related disorders. The…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia
A terminated clinical trial evaluated the safety of risperidone in obese or overweight patients with schizophrenia or schizoaffective disord…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Study of Amantadine for Weight Stabilization During Olanzapine Treatment [Phase 1]
A Phase 1 study evaluating whether amantadine can stabilize weight during olanzapine treatment has been completed.
-
CLINICAL_TRIALS trial_result · 2011-01-04Clinical Trial Update: Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants [Phase 2, Phase 3]
An update on Phase 2 and Phase 3 trials evaluating whether omega-3 fatty acid EPA, combined with antioxidants, can treat schizophrenia and r…
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia [Phase 4]
Phase 4 trial evaluating pregnenolone augmentation in patients with recent-onset schizophrenia; the study status is completed, but no result…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Schizophrenic Patients Taking Part in Integrated Care Program
The AstraZeneca-sponsored clinical trial involving schizophrenia and related psychotic disorders has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-03-25Clinical Trial Update: An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications. [Phase 4]
This update notes the completion of an open-label Phase 4 trial evaluating metformin for weight control in pediatric patients on antipsychot…
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia [Phase 4]
Phase 4 clinical trial update on early onset antipsychotic drug action in schizophrenia and related disorders; results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-03-18Clinical Trial Update: Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia [NA]
A completed clinical trial update evaluating neural inhibition as a mechanism of nicotine dependence in people with schizophrenia and relate…